Amesite Inc.
AMST Nasdaq Services-Prepackaged Software Financials FY2020βFY2026
What Amesite Inc. does
No business description yet.
- Legal name
- Amesite Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Sep 23, 2026
- Accession Β· CIK
- 0001213900-26-102676
0001807166
Revenue and margins
Amesite Inc. had $0.4M of revenue in fiscal 2026, up 230.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$2.2M in fiscal 2026, β590.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amesite Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Amesite Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $7.1M | $5.3M | $2.1M | $2.3M | $2.3M |
| Current ratio | 10.3x | 20.7x | 3.1x | 6.8x | 6.4x |
| Quick ratio | 10.3x | 20.7x | 3.1x | 6.8x | 6.4x |
| Total assets | $8.9M | $6.3M | $3.3M | $3.1M | $3.0M |
| Total liabilities | $0.7M | $0.3M | $0.8M | $0.4M | $0.4M |
| Shareholders' equity | $8.1M | $6.1M | $2.5M | $2.7M | $2.7M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | 2 / 7 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β23.8% | β68.8% | β21.9% | β11.9% | β32.9% | β36.2% | β31.0% |
| Altman Z'' | β | β | β1.02 | 7.83 | β39.82 | β39.04 | β43.08 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $0.1M | $0.7M | $0.7M | $0.8M | $0.2M | $0.1M | $0.4M |
| Research and development | β | β | $3.1M | $1.5M | $1.1M | $0.7M | $0.6M |
| Operating income | β | β | β$9.1M | β$4.2M | β$4.6M | β$3.6M | β$3.1M |
| Net income | β$4.2M | β$11.6M | β$9.1M | β$4.2M | β$4.4M | β$3.6M | β$3.1M |
| Diluted EPS | β | β$0.59 | β$4.67 | β$1.68 | β$1.73 | β$1.03 | β$0.63 |
| Diluted shares | 0.02B | 0.02B | 0.02B | β | β | β | β |
| Cash flow | |||||||
| Cash from operations | β$2.8M | β$5.3M | β$6.7M | β$3.2M | β$2.8M | β$2.5M | β$2.1M |
| Capital expenditure | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M | β | $0.0M |
| Free cash flow | β$2.8M | β$5.4M | β$6.7M | β$3.3M | β$2.8M | β | β$2.2M |
| Depreciation and amortization | $0.5M | $0.8M | $0.9M | $0.7M | $0.5M | $0.4M | $0.3M |
| Stock-based compensation | $0.6M | $0.9M | $1.4M | $0.2M | $0.8M | $0.3M | $0.3M |
| Balance sheet | |||||||
| Cash and short-term investments | $4.1M | $10.7M | $7.1M | $5.3M | $2.1M | $2.3M | $2.3M |
| Current assets | β | $11.1M | $7.7M | $5.5M | $2.5M | $2.4M | $2.4M |
| Current liabilities | $2.7M | $0.7M | $0.7M | $0.3M | $0.8M | $0.4M | $0.4M |
| Property and equipment, net | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | $0.0M |
| Intangible assets | β | β | $0.8M | β | $0.6M | β | β |
| Total assets | $5.7M | $12.5M | $8.9M | $6.3M | $3.3M | $3.1M | $3.0M |
| Total liabilities | $2.7M | $0.7M | $0.7M | $0.3M | $0.8M | $0.4M | $0.4M |
| Preferred stock | β | β | $0.0M | $0.0M | β | β | β |
| Shareholders' equity | $3.0M | $11.7M | $8.1M | $6.1M | $2.5M | $2.7M | $2.7M |
| Margins | |||||||
| Operating margin | β | β | β1,299.4% | β499.9% | β2,744.0% | β3,261.2% | β861.6% |
| EBITDA margin | β | β | β1,173.7% | β419.2% | β2,424.2% | β2,868.6% | β785.6% |
| Net margin | β6,985.4% | β1,717.5% | β1,299.8% | β491.5% | β2,638.2% | β3,273.4% | β848.6% |
| FCF margin | β4,725.1% | β801.7% | β965.9% | β387.7% | β1,686.6% | β | β590.0% |
| Returns | |||||||
| Return on capital employed | β | β | β111.3% | β69.4% | β182.0% | β131.6% | β118.4% |
| Return on equity | β139.0% | β157.3% | β91.2% | β58.4% | β102.4% | β137.7% | β114.8% |
| Return on assets | β73.1% | β127.5% | β84.8% | β54.5% | β91.1% | β112.8% | β101.1% |
| Return on tangible equity | β139.0% | β98.7% | β123.1% | β68.3% | β235.4% | β132.1% | β116.7% |
| Growth | |||||||
| Revenue growth | β | 1,030.0% | 3.3% | 21.2% | β80.2% | β33.8% | 230.1% |
| Share count change | β | 26.8% | 19.3% | β | β | β | β |
| Financial health | |||||||
| Current ratio | β | 14.9x | 10.3x | 20.7x | 3.1x | 6.8x | 6.4x |
| Quick ratio | β | 14.9x | 10.3x | 20.7x | 3.1x | 6.8x | 6.4x |
| Capital allocation | |||||||
| Capex / revenue | 18.1% | 10.9% | 2.4% | 3.2% | 0.7% | β | 1.6% |
| Stock comp / revenue | 929.6% | 129.9% | 206.9% | 21.2% | 500.0% | 291.4% | 73.5% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 2.0 | β | β | β | β |
| Altman Z'' | β | β | β1.0 | 7.8 | β39.8 | β39.0 | β43.1 |
| Accruals ratio | β23.8% | β68.8% | β21.9% | β11.9% | β32.9% | β36.2% | β31.0% |
Source: SEC EDGAR XBRL filings (CIK 0001807166). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.